SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis

Siyu Shen,Haoran Guo,Yan Li,Lili Zhang,Yubin Tang,Huili Li,Xiaohan Li,Pei-Hui Wang,Xiao-Fang Yu,Wei Wei
DOI: https://doi.org/10.1128/jvi.01909-23
IF: 6.549
2024-02-20
Journal of Virology
Abstract:Pyroptosis plays a crucial role in the pathogenesis of coronavirus disease 2019, and comprehending its function may facilitate the development of novel therapeutic strategies. This study aims to explore how viral-encoded proteases modulate pyroptosis. We investigated the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory enterovirus D68 (EV-D68) proteases on host cell pyroptosis. We found that SARS-CoV-2-encoded proteases NSP5 and NSP3 inactivate gasdermin D (GSDMD) but initiate gasdermin E (GSDME)-mediated pyroptosis, respectively. We also discovered that another respiratory virus EV-D68 encodes two distinct proteases 2A and 3C that selectively trigger GSDME-mediated pyroptosis while suppressing the function of GSDMD. Based on these findings, we further noted that EV-D68 infection triggers pyroptosis and produces oncolytic effects in human carcinoma cells. Our study provides new insights into the molecular mechanisms underlying virus-modulated pyroptosis and identifies potential targets for the development of antiviral and cancer therapeutics.
virology
What problem does this paper attempt to address?